High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.

<h4>Introduction</h4>In high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR. However, this approach might miss a substantial proportion of MDR-TB in the general population....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Larissa Otero, Fiorella Krapp, Cristina Tomatis, Carlos Zamudio, Francine Matthys, Eduardo Gotuzzo, Patrick Van der Stuyft, Carlos Seas
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/760ef6b9e93b47e3bbb971def0c93c94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:760ef6b9e93b47e3bbb971def0c93c94
record_format dspace
spelling oai:doaj.org-article:760ef6b9e93b47e3bbb971def0c93c942021-11-18T07:35:37ZHigh prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.1932-620310.1371/journal.pone.0026276https://doaj.org/article/760ef6b9e93b47e3bbb971def0c93c942011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22046266/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4>In high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR. However, this approach might miss a substantial proportion of MDR-TB in the general population. We studied primary MDR in patients considered to be at low risk of MDR-TB in Lima, Peru.<h4>Methods</h4>We enrolled new sputum smear-positive TB patients who did not report any MDR-TB risk factor: known exposure to a TB patient whose treatment failed or who died or who was known to have MDR-TB; immunosuppressive co-morbidities, ex prison inmates; prison and health care workers; and alcohol or drug abuse. A structured questionnaire was applied to all enrolled participants to confirm the absence of these factors and thus minimize underreporting. Sputum from all participants was cultured on Löwenstein-Jensen media and DST for first line drugs was performed using the 7H10 agar method.<h4>Results</h4>Of 875 participants with complete data, 23.2% (203) had risk factors for MDR-TB elicited after enrolment. Among the group with no reported risk factors who had a positive culture, we found a 6.3% (95%CI 4.4-8.3) (37/584) rate of MDR-TB. In this group no epidemiological characteristics were associated with MDR-TB. Thus, in this group, multidrug resistance occurred in patients with no identifiable risk factors.<h4>Conclusions</h4>We found a high rate of primary MDR-TB in a general population with no identifiable risk factors for MDR-TB. This suggests that in a high endemic area targeting patients for MDR-TB based on the presence of risk factors is an insufficient intervention.Larissa OteroFiorella KrappCristina TomatisCarlos ZamudioFrancine MatthysEduardo GotuzzoPatrick Van der StuyftCarlos SeasPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 10, p e26276 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Larissa Otero
Fiorella Krapp
Cristina Tomatis
Carlos Zamudio
Francine Matthys
Eduardo Gotuzzo
Patrick Van der Stuyft
Carlos Seas
High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
description <h4>Introduction</h4>In high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR. However, this approach might miss a substantial proportion of MDR-TB in the general population. We studied primary MDR in patients considered to be at low risk of MDR-TB in Lima, Peru.<h4>Methods</h4>We enrolled new sputum smear-positive TB patients who did not report any MDR-TB risk factor: known exposure to a TB patient whose treatment failed or who died or who was known to have MDR-TB; immunosuppressive co-morbidities, ex prison inmates; prison and health care workers; and alcohol or drug abuse. A structured questionnaire was applied to all enrolled participants to confirm the absence of these factors and thus minimize underreporting. Sputum from all participants was cultured on Löwenstein-Jensen media and DST for first line drugs was performed using the 7H10 agar method.<h4>Results</h4>Of 875 participants with complete data, 23.2% (203) had risk factors for MDR-TB elicited after enrolment. Among the group with no reported risk factors who had a positive culture, we found a 6.3% (95%CI 4.4-8.3) (37/584) rate of MDR-TB. In this group no epidemiological characteristics were associated with MDR-TB. Thus, in this group, multidrug resistance occurred in patients with no identifiable risk factors.<h4>Conclusions</h4>We found a high rate of primary MDR-TB in a general population with no identifiable risk factors for MDR-TB. This suggests that in a high endemic area targeting patients for MDR-TB based on the presence of risk factors is an insufficient intervention.
format article
author Larissa Otero
Fiorella Krapp
Cristina Tomatis
Carlos Zamudio
Francine Matthys
Eduardo Gotuzzo
Patrick Van der Stuyft
Carlos Seas
author_facet Larissa Otero
Fiorella Krapp
Cristina Tomatis
Carlos Zamudio
Francine Matthys
Eduardo Gotuzzo
Patrick Van der Stuyft
Carlos Seas
author_sort Larissa Otero
title High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
title_short High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
title_full High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
title_fullStr High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
title_full_unstemmed High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
title_sort high prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/760ef6b9e93b47e3bbb971def0c93c94
work_keys_str_mv AT larissaotero highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT fiorellakrapp highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT cristinatomatis highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT carloszamudio highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT francinematthys highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT eduardogotuzzo highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT patrickvanderstuyft highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
AT carlosseas highprevalenceofprimarymultidrugresistanttuberculosisinpersonswithnoknownriskfactors
_version_ 1718423229231529984